Reports for RISPERIDONE

Ingredient

RISPERIDONE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-RISPERIDONE 0.50MG TABLET Resolved 2023-11-10 2024-04-26 209957
APO-RISPERIDONE 0.50MG TABLET Resolved 2024-09-27 2025-02-21 238841
APO-RISPERIDONE 0.50MG TABLET Resolved 2025-01-30 2025-02-21 249089
APO-RISPERIDONE 2.0MG TABLET Resolved 2017-06-28 2017-11-30 14219
APO-RISPERIDONE 2.0MG TABLET Resolved 2019-12-12 2020-03-27 101097
APO-RISPERIDONE 2.0MG TABLET Resolved 2024-10-24 2025-02-21 241072
APO-RISPERIDONE 2.0MG TABLET Resolved 2024-03-01 2024-04-26 221090
APO-RISPERIDONE 2.0MG TABLET Resolved 2024-10-10 2025-02-14 239819
APO-RISPERIDONE 2.0MG TABLET Resolved 2023-12-22 2024-05-03 214247
APO-RISPERIDONE 3.0MG TABLET Resolved 2020-06-10 2020-07-13 117407

Showing 11 to 20 of 158

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-RISPERIDONE 3.0MG TABLET Discontinued 2018-09-08 2019-06-12 60750
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2018-09-08 2018-09-08 60753
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2019-03-11 2019-03-11 78260
MYLAN-RISPERIDONE 0.25MG TABLET Discontinued 2017-07-18 2018-02-15 16154
MYLAN-RISPERIDONE 0.50MG TABLET Discontinued 2017-07-18 2018-02-15 16157
MYLAN-RISPERIDONE 1.0MG TABLET Discontinued 2017-07-18 2017-09-08 16160
MYLAN-RISPERIDONE 2.0MG TABLET Discontinued 2017-07-18 2017-10-03 16163
MYLAN-RISPERIDONE 3.0MG TABLET Discontinued 2017-07-18 2017-10-03 16166
MYLAN-RISPERIDONE 4.0MG TABLET Discontinued 2017-07-18 2017-10-03 16169
MYLAN-RISPERIDONE ODT 3MG TABLET (ORALLY DISINTEGRATING) Discontinued 2021-11-23 2021-11-23 149768

Showing 1 to 10 of 29